IBRX - Immunitybio - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IBRX is currently covered by 6 analysts with an average price target of $11.67. This is a potential upside of $4.67 (31.57%) from yesterday's end of day stock price of $8.87.

Immunitybio's activity chart (see below) currently has 30 price targets and 43 ratings on display. The stock rating distribution of IBRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75.45% with an average time for these price targets to be met of 269.75 days.

Highest price target for IBRX is $23, Lowest price target is $7, average price target is $11.67.

Most recent stock forecast was given by from D. BORAL CAPITAL on 05-May-2026. First documented stock forecast 24-Aug-2015.

Best performing analysts who are covering IBRX - Immunitybio:

Biren Amin Kelly Shi Andrew Fein Andres Maldonado Justin Zelin Joel Beatty

Currently out of the existing stock ratings of IBRX, 18 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 20-Jan-2026

$23

$14.29 (164.06%)

$23

2 months 4 days ago
(05-May-2026)

0/10 (0%)

$15.42 (203.43%)

Buy Since 04-Mar-2026

$12

$3.29 (37.77%)

$5

4 months 5 days ago
(04-Mar-2026)

1/2 (50%)

$3 (33.33%)

241

Buy Since 06-Mar-2025

$10

$1.29 (14.81%)

$8

5 months 13 days ago
(26-Jan-2026)

8/8 (100%)

$3.79 (61.03%)

253

Buy Since 10-Jan-2025

$9

$0.29 (3.33%)

$6

5 months 16 days ago
(23-Jan-2026)

3/3 (100%)

$2.55 (39.53%)

220

Buy Since 20-Jan-2026

$7

$-1.71 (-19.63%)

$4.25

5 months 19 days ago
(20-Jan-2026)

7/11 (63.64%)

$0.52 (8.02%)

92

Show more analysts

Please expand the browser size to see the chart

What is IBRX (Immunitybio) average time for price targets to be met?

On average it took 269.75 days on average for the stock forecasts to be realized with a an average price target met ratio 75.45

Which analyst has the current highest performing score on IBRX (Immunitybio) with a proven track record?

BIREN AMIN

Which analyst has the most public recommendations on IBRX (Immunitybio)?

Biren Amin works at PIPER SANDLER and has 5 price targets and 7 ratings on IBRX

Which analyst is the currently most bullish on IBRX (Immunitybio)?

Jason Kolbert with highest potential upside - $14.29

Which analyst is the currently most reserved on IBRX (Immunitybio)?

Joel Beatty with lowest potential downside - -$7.67

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?